SELLAS Life Sciences Group: Pay

SELLAS Life Sciences Group paid its one named executive on file $778.5K in FY2023 (Dec).

Pay$100 in the stock at the end of FY21 → $43
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Angelos M. Stergiou, M.D., Sc.D. h.c.President and Chief Executive Officer
FY2022 (Dec)
1 year
Dragan Cicic, M. D.Senior Vice President, Chief Development Officer
FY2023 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 3 peers with pay on file was $5.1M. The CEO of SELLAS Life Sciences Group was paid $1.9M, 63% below the median.

  1. 1Corvus Pharmaceuticals
  2. 2Compass Therapeutics
  3. 3Verastem
  4. 4SELLAS Life Sciences Group
  5. 5Actinium Pharmaceuticals, Inc.Not disclosed
  6. 6BeyondSpring Inc.Not disclosed
  7. 7Cardiff OncologyNot disclosed
  8. 8Cellectar Biosciences, Inc.Not disclosed
  9. 9Checkpoint Therapeutics, Inc.Not disclosed
  10. 10Cidara Therapeutics, Inc.Not disclosed
  11. 11Cue Biopharma, Inc.Not disclosed
  12. 12Elevation Oncology, Inc.Not disclosed
  13. 13Equillium, Inc.Not disclosed
  14. 14Genelux CorporationNot disclosed
  15. 15Immunic, Inc.Not disclosed
  16. 16Leap Therapeutics, Inc.Not disclosed
  17. 17PDS Biotechnology CorporationNot disclosed
  18. 18Syros PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.